Advertisement
UK markets close in 7 hours 5 minutes

  • FTSE 100

    8,054.23
    +30.36 (+0.38%)
     

  • FTSE 250

    19,686.33
    +86.94 (+0.44%)
     

  • AIM

    752.10
    +2.92 (+0.39%)
     

  • GBP/EUR

    1.1577
    -0.0012 (-0.10%)
     

  • GBP/USD

    1.2364
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    53,521.85
    -31.14 (-0.06%)
     

  • CMC Crypto 200

    1,393.80
    -20.96 (-1.48%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    82.67
    +0.77 (+0.94%)
     

  • GOLD FUTURES

    2,320.10
    -26.30 (-1.12%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    17,982.02
    +121.22 (+0.68%)
     

  • CAC 40

    8,057.91
    +17.55 (+0.22%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

BUZZ-UDG Healthcare: Sharp's impact

Reuters - UK Focus

** Shares (Berlin: DI6.BE - news) of healthcare services provider down 6.3 pct and set for worst day since November 2016

** Co posts a 17 pct rise in H1 net revenue to $568.7 mln, reiterates guidance for FY2018 constant currency adjusted EPS growth

** However, Liberum says that "some investors will be disappointed by the lack of a guidance upgrade and the weaker Sharp (Swiss: SHA.SW - news) figures"

** Co's Sharp division reports a 7 pct fall in H1 revenue and decline in oper. profit of 2 pct, hit by increased contract churn in H2 2017 - per Jefferies

** The broker adds that Sharp, which specialises in contract packaging and clinical trial supply chain solutions services, was expected to be H2 weighted, but the ramp up was expected to be faster

** The stock is among the worst performers on Stoxx 600 index